Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

from The Chain: Protein Engineering Podcast · host Cambridge Healthtech Institute

Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.

Episode metadata supplied by the publisher feed · Published Mar 18, 2020

Embed this episode

Attribution link and audio player

Ready to play

Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

0:00 23:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Chain: Protein Engineering Podcast?

This episode is 23 minutes long.

When was this The Chain: Protein Engineering Podcast episode published?

This episode was published on March 18, 2020.

Can I download this The Chain: Protein Engineering Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!